Literature DB >> 12085232

Differential regulation of Rb family proteins and prohibitin during camptothecin-induced apoptosis.

Gina Fusaro1, Sheng Wang, Srikumar Chellappan.   

Abstract

Prohibitin, a potential tumor suppressor, is known to induce growth suppression and repress E2F-mediated transcription. These growth regulatory functions of prohibitin require a physical interaction with the Rb protein. We now find that prohibitin protects cells from apoptosis mediated by camptothecin, a topoisomerase I inhibitor. Camptothecin treatment of Ramos B cells leads to the degradation of Rb protein and phosphorylation of its family members, p107 and p130. This correlates with an increase in the levels of cyclin E as well as the kinase activity associated with it. Inactivation of Rb leads to the dissociation and release of free E2F. We find also that E2F activity is induced upon camptothecin treatment, but this increase is absent in prohibitin overexpressing cells. It thus appears that prohibitin may be inhibiting apoptosis by downregulating E2F activity when Rb family members are inactive.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12085232     DOI: 10.1038/sj.onc.1205551

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  32 in total

1.  Regulation of neuron survival and death by p130 and associated chromatin modifiers.

Authors:  David X Liu; Niharika Nath; Srikumar P Chellappan; Lloyd A Greene
Journal:  Genes Dev       Date:  2005-03-15       Impact factor: 11.361

2.  Disruption of the Rb--Raf-1 interaction inhibits tumor growth and angiogenesis.

Authors:  Piyali Dasgupta; Jiazhi Sun; Sheng Wang; Gina Fusaro; Vicki Betts; Jaya Padmanabhan; Saïd M Sebti; Srikumar P Chellappan
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

3.  Dingxin recipe ( ) prevents ischemia/reperfusion-induced arrhythmias via up-regulating prohibitin and suppressing inflammatory responses.

Authors:  Yu-Hua Jia; Yun-Xian Zhang; Li-Jun Li; Ya-Wei Liu; Chun-Hua Li; Xiu-Qiong Fu; Ping Zeng; Wei-Kang Wu; Xue-Gang Sun
Journal:  Chin J Integr Med       Date:  2012-02-05       Impact factor: 1.978

4.  Differential regulation of human YY1 and caspase 7 promoters by prohibitin through E2F1 and p53 binding sites.

Authors:  B Joshi; S Rastogi; M Morris; L M Carastro; C DeCook; E Seto; S P Chellappan
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

5.  Prohibitin suppresses renal interstitial fibroblasts proliferation and phenotypic change induced by transforming growth factor-beta1.

Authors:  Wei Guo; Hong Xu; Jing Chen; Yong Yang; Jia Wei Jin; Rui Fu; Hai Mei Liu; Xi Liang Zha; Zhi Gang Zhang; Wen Yan Huang
Journal:  Mol Cell Biochem       Date:  2006-10-17       Impact factor: 3.396

6.  Identification of new modulators and protein alterations in non-apoptotic programmed cell death.

Authors:  Sabina Sperandio; Karen S Poksay; Birgit Schilling; Danielle Crippen; Bradford W Gibson; Dale E Bredesen
Journal:  J Cell Biochem       Date:  2010-12-15       Impact factor: 4.429

7.  Vi polysaccharide of Salmonella typhi targets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses.

Authors:  Amita Sharma; Ayub Qadri
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-02       Impact factor: 11.205

8.  Prohibitins are required for cancer cell proliferation and adhesion.

Authors:  Claudia Sievers; Gwendolyn Billig; Kathleen Gottschalk; Thomas Rudel
Journal:  PLoS One       Date:  2010-09-14       Impact factor: 3.240

9.  Proteomic analysis of human bone marrow mesenchymal stem cells transduced with human telomerase reverse transcriptase gene during proliferation.

Authors:  G P Huang; Z J Pan; J P Huang; J F Yang; C J Guo; Y G Wang; Q Zheng; R Chen; Y L Xu; G Z Wang; Y M Xi; D Shen; J Jin; J F Wang
Journal:  Cell Prolif       Date:  2008-06-19       Impact factor: 6.831

10.  Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours.

Authors:  D Alwyn Dart; Bradley Spencer-Dene; Simon C Gamble; Jonathan Waxman; Charlotte L Bevan
Journal:  Endocr Relat Cancer       Date:  2009-07-27       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.